• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 8, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

The search for obesity drugs targets hunger’s complex chemistry

Bioengineer by Bioengineer
March 29, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Discoveries of hormones related to weight and appetite in the '90s helped spur a search for obesity treatments targeting those hormones– with disappointing results. Now scientists are taking a new tack that could finally yield promising treatments, according to a story in Chemical & Engineering News (C&EN) that was produced in collaboration with the American Chemical Society's open-access journal ACS Central Science. C&EN is the weekly newsmagazine of ACS.

Jyoti Madhusoodanan, a contributing editor at C&EN, reports that early attempts to therapeutically target leptin and ghrelin — which suppress and stimulate appetite, respectively — were mostly ineffective. But the hormones' discoveries paved the way to a deeper understanding of the chemistry of hunger. Scientists have found that in addition to leptin and ghrelin, many other factors contribute to eating habits. Protein sensors in the stomach, for example, sense stretch, pressure and volume changes when a person eats, and create a sense of fullness. Neurotransmitters in the brain, including dopamine, serotonin and norepinephrine, also tweak people's feelings of hunger and satiety.

Recognizing the role of the brain in weight gain, researchers developed newer therapies, approved in 2013 and 2014, to target individual neuronal signaling molecules. But to further improve obesity treatments, drugs will most likely need a more complex approach, given the multiple factors involved in hunger. So researchers are now trying combination therapies to better regulate various parts of the body's appetite control system. A few more years of research could ultimately bear out this strategy — or help redirect the field yet again.

###

The article, "Hungering for obesity treatments," is freely available here.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With nearly 157,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected].

Follow us on Twitter | Facebook

Media Contact

Katie Cottingham
[email protected]
301-775-8455
@ACSpressroom

http://www.acs.org

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Genomic prediction models tested for timothy grass across Norwegian environments

Genomic prediction models tested for timothy grass across Norwegian environments

September 8, 2026
Simple buffered chromatin purification enables high-yield plant proteomics and epigenomics

Simple buffered chromatin purification enables high-yield plant proteomics and epigenomics

September 8, 2026

ZNF143 drives fatty liver disease by suppressing mitophagy through SMURF1/TRPV1

September 8, 2026

Chitosan-templated MgO nanorods made via green synthesis boost hydrazine electrooxidation

September 8, 2026
Please login to join discussion

POPULAR NEWS

  • Genomic prediction models tested for timothy grass across Norwegian environments

    29 shares
    Share 12 Tweet 7
  • Simple buffered chromatin purification enables high-yield plant proteomics and epigenomics

    29 shares
    Share 12 Tweet 7
  • ZNF143 drives fatty liver disease by suppressing mitophagy through SMURF1/TRPV1

    29 shares
    Share 12 Tweet 7
  • Chitosan-templated MgO nanorods made via green synthesis boost hydrazine electrooxidation

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Genomic prediction models tested for timothy grass across Norwegian environments

Simple buffered chromatin purification enables high-yield plant proteomics and epigenomics

ZNF143 drives fatty liver disease by suppressing mitophagy through SMURF1/TRPV1

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.